How much funding has Delox raised?

Delox has raised $3.4M in total funding, most recently a Series A round.

Who are Delox's investors?

Delox's investors include Caixa Capital, European Investment Bank.

Where is Delox headquartered?

Delox is headquartered in Lisbon.

What industry is Delox in?

Delox operates in Biotech, Healthcare, Life Sciences.

Delox

Advanced Bio-Decontamination for Critical Environments

Lisbon · Founded 2018 · $3.4M raised

Biotech

Healthcare

Life Sciences

Headquarters: Lisbon
Founded: 2018
Business Model: B2B
Website: delox-global.com

Total Funding: $3.4M
Last Round: $1.7M Series AFeb 2026
Rounds: 3

About

Delox is an international technology company developing advanced bio-decontamination solutions for the world's most demanding environments, including small enclosures, laboratory equipment, and other spaces requiring strict contamination control. Its DeloxHP vaporized hydrogen peroxide (VHP) technology achieves up to 99.9999% microorganism elimination (Log-6 reduction) while breaking down into water and oxygen with no toxic residues, supporting microbiological safety and regulatory compliance in critical environments.

Summary

Delox is a Biotech company based in Lisbon, founded in 2018. It has raised $3.4M in total across 3 rounds, most recently a $1.7M Series A round in Feb 2026. Investors include Caixa Capital and European Investment Bank.